CHD1L and cancer: Targeting Chromodomain Helicase DNA-Binding-Protein 1-Like (CHD1L), also known as Amplified in Liver Cancer-1 (ALC1), offers a promising strategy to combat these challenges and improve survival outcomes for cancer patients.